Follow
Xintela AB
Nasdaq First North GM (Sweden)
Xintela AB is a Swedish biomedical company working in the fields of regenerative medicine and cancer, with focus on cartilage damage and brain tumours. The key to company's operations is the company's patented marker technology Xinmark. Its markers are specific proteins which work as recognition flags on the surface of certain cells.
Sector:
HEALTH CARE
>
Biotechnology
Healthcare
Exercise
Price
Exercise period(s)
04 Nov - 18 Nov 2020
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
XINT
SE0007756903
Nasdaq First North GM
Sweden (SE)
Details of share in Xintela AB with ticker XINT
Status
Active
Order book id
Amount of instruments
57 542 856
Par value
0.0300
Market cap
Currency
SEK
Segment
First North
First trading date
22 Mar 2016
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
5.00 SEK
89M SEK
03 Feb - 17 Feb 2016
IPO in Xintela AB
Type
Price
Pre-money valuation
Time
Files
Exercise
5.00 SEK
30 Jan - 10 Feb 2017
Option exercise terms for XINT TO1
Type
Price
Pre-money valuation
Time
Files
Targeted issue
6.00 SEK
182.21M SEK
28 Sep 2018
Share issue in Xintela AB
Type
Price
Pre-money valuation
Time
Files
Targeted issue
6.00 SEK
236.8M SEK
27 Dec 2019
Share issue in Xintela AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
2.40 SEK
97.9M SEK
24 Jun - 08 Jul 2020
Share issue in Xintela AB
Type
Ticker
ISIN
Market
OPTION
XINT TO 2
SE0014555074
Nasdaq First North GM
Sweden (SE)
Details of option in Xintela AB with ticker XINT TO 2
Status
Active
Order book id
201353
Amount of instruments
16 754 112
Market cap
Currency
SEK
Segment
First North
Trading period
19 Aug 2020 - 11 Nov 2020
Terms
The subscription price for subscription of shares based on warrants amounts to 70 percent of the volume weighted average price of the Company's share on the Nasdaq First North Growth Market during a period of ten (10) trading days immediately preceding, and including, October 30, 2020 prior to the exercise period of the respective series. of warrants. However, the subscription price cannot be less than SEK 1.92 per share.
Type
Price
Pre-money valuation
Time
Files
Exercise
04 Nov - 18 Nov 2020
Option exercise terms for XINT TO 2
Type
Ticker
ISIN
Market
SHARE
XINT
SE0007756903
Nasdaq First North GM
Sweden (SE)
Details of share in Xintela AB with ticker XINT
Status
Active
Order book id
Amount of instruments
57 542 856
Par value
0.0300
Market cap
Currency
SEK
Segment
First North
First trading date
22 Mar 2016
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
5.00 SEK
89M SEK
03 Feb - 17 Feb 2016
IPO in Xintela AB
Type
Price
Pre-money valuation
Time
Files
Targeted issue
6.00 SEK
182.21M SEK
28 Sep 2018
Share issue in Xintela AB
Type
Price
Pre-money valuation
Time
Files
Targeted issue
6.00 SEK
236.8M SEK
27 Dec 2019
Share issue in Xintela AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
2.40 SEK
97.9M SEK
24 Jun - 08 Jul 2020
Share issue in Xintela AB
Type
Ticker
ISIN
Market
OPTION
XINT TO1
SE0007783543
Nasdaq First North GM
Sweden (SE)
Details of option in Xintela AB with ticker XINT TO1
Status
Archived
Order book id
120380
Amount of instruments
Market cap
Currency
SEK
Trading period
22 Mar 2016 - 08 Feb 2017
Terms
One (1) warrant TO1 entitle to subscribe for one (1) new share in the Company.
Type
Price
Pre-money valuation
Time
Files
Exercise
5.00 SEK
30 Jan - 10 Feb 2017
Option exercise terms for XINT TO1
Type
Ticker
ISIN
Market
OPTION
XINT TO 2
SE0014555074
Nasdaq First North GM
Sweden (SE)
Details of option in Xintela AB with ticker XINT TO 2
Status
Active
Order book id
201353
Amount of instruments
16 754 112
Market cap
Currency
SEK
Segment
First North
Trading period
19 Aug 2020 - 11 Nov 2020
Terms
The subscription price for subscription of shares based on warrants amounts to 70 percent of the volume weighted average price of the Company's share on the Nasdaq First North Growth Market during a period of ten (10) trading days immediately preceding, and including, October 30, 2020 prior to the exercise period of the respective series. of warrants. However, the subscription price cannot be less than SEK 1.92 per share.
Type
Price
Pre-money valuation
Time
Files
Exercise
04 Nov - 18 Nov 2020
Option exercise terms for XINT TO 2
People
Number of Employees
15 people
Evy Kristina Lundgren Åkerlund
CEO
Gregory Batcheller
Chairman of the board
Sven Kili
Board member
Peter Edman
Board member
Karin Wingstrand
Board member
Gregory Batcheller
Board member
Company Details
Sector
HEALTH CARE
Website

Address
C/O Xintela AB
Zip code
223 81
City/district
Lund
Country
Sweden (SE)
Registration number
556780-3480
LEI code
549300SMDH1EOLCBQU68
First trade date
22 Mar 2016
Registration date
02 Apr 2009
Short name
Xintela

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date